We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Dorian LPG
LPG
$1.97B
| $394K | 0.01% |
+19,769
| New | +$402K |
|
1252
Camping World
CWH
$694M
| $393K | 0.01% |
+18,852
| New | +$440K |
|
1253
The Greenbrier Companies
GBX
$1.54B
| $393K | 0.01% |
+12,214
| New | +$369K |
|
|
MDNA
1254
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $392K | 0.01% |
603,407
+64,356
| +12% | +$40.1K |
|
|
DAWN
1255
DELISTED
Day One Biopharmaceuticals
DAWN
| $392K | 0.01% |
+29,331
| New | +$573K |
|
1256
Elanco Animal Health
ELAN
$12.8B
| $392K | 0.01% |
41,713
-6,379
| -13% | -$75.3K |
|
1257
NeoGenomics
NEO
$2.04B
| $388K | 0.01% |
+22,295
| New | +$318K |
|
1258
CALL
Agilent Technologies
A
$39.5B
| $387K | 0.01% |
2,800
-300
| -10% | -$43.9K |
|
1259
BCE
BCE
$20.3B
| $387K | 0.01% |
8,648
+1,851
| +27% | +$83.6K |
|
1260
Immunovant
IMVT
$7.91B
| $386K | 0.01% |
+24,910
| New | +$432K |
|
1261
Chemed
CHE
$7.18B
| $383K | 0.01% |
+713
| New | +$364K |
|
1262
CPI Card Group
PMTS
$252M
| $382K | 0.01% |
+8,498
| New | +$315K |
|
1263
Boston Scientific
BSX
$72B
| $382K | 0.01% |
7,628
-9,603
| -56% | -$453K |
|
|
ACLX
1264
DELISTED
Arcellx
ACLX
| $380K | 0.01% |
+12,345
| New | +$374K |
|
1265
Golar LNG
GLNG
$5B
| $380K | 0.01% |
17,586
-10,578
| -38% | -$237K |
|
|
CONX
1266
DELISTED
CONX Corp. Class A Common Stock
CONX
| $380K | 0.01% |
37,121
| – | – |
|
|
TWKS
1267
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $378K | 0.01% |
+51,363
| New | +$476K |
|
1268
TG Therapeutics
TGTX
$7.07B
| $376K | 0.01% |
+24,995
| New | +$380K |
|
1269
CALL
LyondellBasell Industries
LYB
$19.6B
| $376K | 0.01% |
4,000
-6,500
| -62% | -$605K |
|
1270
Hasbro
HAS
$12.9B
| $374K | 0.01% |
6,975
-13,320
| -66% | -$761K |
|
1271
Tandem Diabetes Care
TNDM
$1.38B
| $371K | 0.01% |
+9,141
| New | +$378K |
|
1272
Church & Dwight Co
CHD
$23.7B
| $371K | 0.01% |
4,193
-18,659
| -82% | -$1.56M |
|
1273
Avnet
AVT
$7.29B
| $370K | 0.01% |
8,190
-10
| -0.1% | -$446 |
|
1274
Bally's
BALY
$689M
| $370K | 0.01% |
+18,953
| New | +$372K |
|
1275
Bank OZK
OZK
$5.65B
| $368K | 0.01% |
10,758
-2,979
| -22% | -$125K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.